KPIs & Operating Metrics(New)
Growth Metrics

Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $290.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 5.54% to $290.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, down 4.66% year-over-year, with the annual reading at $1.2 billion for FY2025, 4.66% down from the prior year.
  • Depreciation & Amortization (CF) hit $290.0 million in Q4 2025 for Bausch Health Companies, down from $306.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $404.0 million in Q2 2021 to a low of $290.0 million in Q4 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $334.2 million across 5 years, with a median of $321.0 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 16.22% in 2021 and later grew 6.98% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $363.0 million in 2021, then fell by 0.83% to $360.0 million in 2022, then decreased by 8.61% to $329.0 million in 2023, then fell by 6.69% to $307.0 million in 2024, then decreased by 5.54% to $290.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for BHC at $290.0 million in Q4 2025, $306.0 million in Q3 2025, and $307.0 million in Q2 2025.